Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PRGN-3007 |
Synonyms | |
Therapy Description |
PRGN-3007 are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting ROR1, membrane-bound IL-15, and kill switch genes, which potentially induce cytotoxicity against ROR1-expressing tumor cells and reduce tumor growth (Blood (2021) 138 (Supplement 1): 1694). |